TD Cowen initiated coverage of Kiniksa (KNSA) with a Buy rating and $60 price target The firm says Kiniksa is at a “pivotal stage” as Arcalyst’s launch continues to ramp while KPL-387 could offer more favorable dosing. This could extend the franchise and significantly improve the company’s earnings, the analyst tells investors in a research note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KNSA: